We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AUPH market cap is 1.13B. The company's latest EPS is USD 0.0402 and P/E is 196.77.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 54.43M | 57.48M | 67.77M | 64.21M | 62.47M |
| Operating Income | -13.25M | -1.51M | 16.32M | -1.83M | 26.28M |
| Net Income | -10.75M | 722k | 14.35M | 1.43M | 23.34M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 50.12M | 45.61M | 135.55M | 175.51M | 239.48M |
| Operating Income | -104.29M | -180.74M | -111.47M | -91.69M | -4.69M |
| Net Income | -102.68M | -180.97M | -108.18M | -78.02M | 5.75M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 516.63M | 523.53M | 549.36M | 550.65M | 504.85M |
| Total Liabilities | 157.16M | 158.91M | 161.36M | 173.17M | 154.66M |
| Total Equity | 359.48M | 364.62M | 388M | 377.48M | 350.19M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 463.66M | 543.37M | 470.86M | 548.06M | 550.65M |
| Total Liabilities | 55.91M | 64.28M | 65.43M | 170.11M | 173.17M |
| Total Equity | 407.75M | 479.09M | 405.44M | 377.95M | 377.48M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.6M | -2.76M | 14.27M | 44.39M | 1.3M |
| Investing | 49.23M | 10.61M | 39k | 39.26M | 31.03M |
| Financing | -15.05M | -23.32M | -26.05M | -49.09M | -49.34M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -69.86M | -157.69M | -79.53M | -33.46M | 44.39M |
| Investing | -158.19M | -103.87M | -60.63M | -6.71M | 39.26M |
| Financing | 194.38M | 221.11M | 2.43M | -5.13M | -49.09M |
| Market Cap | 1.13B |
| Price to Earnings Ratio | 196.77 |
| Price to Sales Ratio | 4.72 |
| Price to Cash Ratio | 13.56 |
| Price to Book Ratio | 3 |
| Dividend Yield | - |
| Shares Outstanding | 142.99M |
| Average Volume (1 week) | 899.87k |
| Average Volume (1 Month) | 1.13M |
| 52 Week Change | 41.00% |
| 52 Week High | 10.67 |
| 52 Week Low | 5.195 |
| Spread (Intraday) | 0.13 (1.62%) |
| Company Name | Aurinia Pharmaceuticals Inc |
| Address |
1203-4464 markham street victoria, british columbia V8Z 7X8 |
| Website | https://www.auriniapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
